全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Mohamed Faisal Lutfi
来源:[J].Multidisciplinary Respiratory Medicine(IF 0.151), 2017, Vol.12 (1)Springer
摘要:From a physiological standpoint, the lung volumes are either dynamic or static. Both subclasses are measured at different degrees of inspiration or expiration; however, dynamic lung volumes are characteristically dependent on the rate of air flow. The static lung volumes/capaciti...
作者:Takashi Nojiri , Haruko Yamamoto , Toshimitsu Hamasaki ...
来源:[J].Trials(IF 2.206), 2017, Vol.18 (1)Springer
摘要:... In a previous retrospective study of lung cancer surgery, we reported that administration of atrial natriuretic peptide (ANP) during the perioperative period reduced postoperative recurrence. We demonstrated that ANP inhibited the adhesion of cancer cells to vascular endothel...
作者:Maria Iachina , Erik Jakobsen , Anne Kudsk Fallesen ...
来源:[J].BMC Health Services Research(IF 1.773), 2017, Vol.17 (1)Springer
摘要:Lung cancer is the second most frequent cancer diagnosis in Denmark. Although improved during the last decade, the prognosis of lung cancer is still poor with an overall 5-year survival rate of approximately 12%. Delay in diagnosis and treatment of lung cancer has been suggested ...
作者:Shibing Yu , Mitchell Stephen Fourman , Adel Mahjoub ...
来源:[J].BMC Cancer(IF 3.333), 2017, Vol.17 (1)Springer
摘要:Osteosarcoma (OS) is the most common primary bone tumor, with a propensity to metastasize to the lungs. Five-year survival for metastatic OS is below 30%, and has not improved for several decades despite the introduction of multi-agent chemotherapy. Understanding OS cell migratio...
作者:Shouichi Okamoto , Shinsaku Togo , Ichiro Nagata ...
来源:[J].BMC Cancer(IF 3.333), 2017, Vol.17 (1)Springer
摘要:Receptor for advanced glycation end-products (RAGE), a receptor for amyloids, is constitutively expressed in lungs and generally observed to be downregulated in lung cancer tissues. However, increasing levels of RAGE or serum amyloids is associated with poor outcome in lung cance...
作者:Sang Min Park , Jongmog Lee , Young Ae Kim ...
来源:[J].BMC Cancer(IF 3.333), 2017, Vol.17 (1)Springer
摘要:Lung cancer survivors are more likely to develop colorectal and stomach cancer than the general population. However, little is known about the current status of gastrointestinal cancer screening practices and related factors among lung cancer survivors.
作者:Anika Sparla , Sebastian Flach-Vorgang , Matthias Villalobos ...
来源:[J].BMC Health Services Research(IF 1.773), 2017, Vol.17 (1)Springer
摘要:Lung cancer patients are often diagnosed in an advanced stage of disease. In a situation of palliative treatment, both patients and their relatives experience existential burden. Evidence suggests that multi-professional teams should deal with them as dyads. However, little is kn...
作者:Tatsuya Nitawaki , Yoshihiko Sakata , Kodai Kawamura ...
来源:[J].BMC Pulmonary Medicine(IF 2.76), 2017, Vol.17 (1)Springer
摘要:Alectinib, a second-generation anaplastic lymphoma kinase (ALK) inhibitor, is a key drug for ALK rearranged lung adenocarcinoma. Interstitial lung disease (ILD) is an important adverse effect of alectinib, which generally requires termination of treatment. However, we treated two...
作者:Bethan A. Frugtniet , Tracey A. Martin , Lijian Zhang ...
来源:[J].BMC Cancer(IF 3.333), 2017, Vol.17 (1)Springer
摘要:Lung cancer is one of the most commonly diagnosed cancers with survival much lower in patients diagnosed with distal metastases. It is therefore imperative to identify pathways involved in lung cancer invasion and metastasis and to consider the therapeutic potential of agents tha...
作者:Kota Nakamura , Motoyasu Kato , Takehito Shukuya ...
来源:[J].BMC Cancer(IF 3.333), 2017, Vol.17 (1)Springer
摘要:Interstitial lung diseases induced by anticancer agents (ILD-AA) are rare adverse effects of anticancer therapy. However, prognostic biomarkers for ILD-AA have not been identified in patients with advanced lung cancer. Our aim was to analyze the association between serum biomarke...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×